Plus: FDA recalls Minimed, requests withdrawal of Belviq: passive smoking and diabetes; more
Can't see the images? View as webpage.
Facebook
Twitter
LinkedIn
To ensure that you never miss an issue, please whitelist us.

Feb. 15, 2020 : Issue #1029

TOP STORIES - Diabetes News & Research

Beverage Choices and Their Effects on Risk of Developing Diabetes 

Risk of Developing Type 2 Diabetes with Passive Smoking 

Depression and Hyperglycemic Crisis 
Letter from the Editor
Feb. 15, 2020

Here’s 3 things you need to know.

First, drink coffee; second, get rid of sugary drinks but don’t change to artificially sweetened drinks; and thirdly, stay away from second hand smoke. If none of this makes sense to you, then I suggest you read this week’s edition of our newsletter so you can find our why.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief


Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.

Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.

Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.

Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.

Visit Doctor's Option

NEWSFLASH

FDA RECALL: MiniMed 600 Insulin Pumps

MiniMed 600 Series Insulin Pumps recalled due to incorrect insulin dosing.  More Information
 

FDA Requests Withdrawal of Weight-Loss Drug

The FDA has requested withdrawal of Belviq, Belviq XR (lorcaserin) by Eisai because a clinical safety trial shows an increased occurrence of pancreatic, colorectal, and lung cancer.  When FDA approved lorcaserin in 2012, they required the drug manufacturer to conduct a clinical trial to evaluate the risk of cardiovascular problems, and a range of cancer types was reported more frequently in the lorcaserin group.  FDA MedWatch 

TOP STORIES - Diabetes News and Research

Beverage Choices and Their Effects on Risk of Developing Diabetes 
How much can one drink matter? Quite a bit, as it turns out. 
READ MORE
Risk of Developing Type 2 Diabetes with Passive Smoking 
Inhaling secondhand smoke (SHS), also known as passive smoking, could lead to the development of type 2 diabetes.
READ MORE
Depression and Hyperglycemic Crisis
People who have diabetes and depression have a higher risk of complications from both diseases
READ MORE

Did You Know:   Can Coffee Improve Your Workout?


Does drinking coffee enhance exercise performance? Researchers have consistently shown that coffee’s high energy ingredient, caffeine, is a well-established ergogenic aid, with performance-enhancing effects across a range of sports and exercises. But much of this research has used caffeine supplements or powder, not coffee, as the test substance.  In an umbrella review in the British Journal of Sports Medicine , researchers summarized findings from all meta-analyses that explored the effects of caffeine on athletic performance.  What they found was that caffeine could enhance the ability to run and cycle for more extended periods, or to complete a given distance in a shorter time frame. It could also allow us to perform more repetitions with a given weight in the gym, or to increase the total weight lifted,” the authors wrote in an explanatory article on TheConversation.com . They found that caffeine boosted sports performance by about 2% and 6%, and when the caffeine dose is matched, caffeine supplements and coffee seem to be equally beneficial for improving performance.  

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Nadeen Ayad, BCPS, PharmD Candidate, Skaggs School of Pharmacy, University of Colorado

Antonio Bess, Pharm D Candidate, Florida Agricultural & Mechanical University School of Pharmacy

George McConnell, PharmD. Candidate, LECOM School of Pharmacy

Sandra Zaki, PharmD Candidate, Florida A&M University
 About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
Facebook
Twitter
LinkedIn
©2020 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of:
Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States

DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe